Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam adjunctive therapy for partial-onset seizures
ChiCTR2400081880Phase 3Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of brivaracetam in Focal Onset Epilepsy and Focal onset seizure (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Percent reduction in partial-onset seizure frequency versus control during 12 weeks. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
brivaracetam
03
Conditions
Focal Onset EpilepsyFocal onset seizure
Beyond the preview
Go deeper on ChiCTR2400081880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081880.